FDA approval boosts weight loss pill co Epitomee - Globes English - גלובס
Epitomee Medical received FDA approval for its weight management pill, causing a 152% share price surge. Despite Nestlé's withdrawal from marketing, CEO Dan Hashimshony plans to sign distribution agreements for a 2025 launch. The pill targets low to medium obesity and avoids injection-based treatments.
Reference News
FDA approval boosts weight loss pill co Epitomee - Globes English - גלובס
Epitomee Medical received FDA approval for its weight management pill, causing a 152% share price surge. Despite Nestlé's withdrawal from marketing, CEO Dan Hashimshony plans to sign distribution agreements for a 2025 launch. The pill targets low to medium obesity and avoids injection-based treatments.